This site is intended for healthcare professionals
News

Fulcrum THerapeutics initiates phase III trial of losmapimod to treat COVID-19.

Read time: 1 mins
Last updated:25th Jun 2020
Published:25th Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com